How to Invest in Pot Stocks in 2020

Discover what makes pots stocks like Cronos Group (TSX:CRON)(NASDAQ:CRON) superior investments in the year to come.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

Pot stocks are on the rebound. Since the start of the year, many marijuana stocks are up by more than 10%. That’s not a huge bump, but it’s a welcome event following a disastrous 2019. Last year, the cannabis market at large was down by more than 50%.

As with any emerging market, volatility should have been expected. Yet last year’s downturn has turned off thousands of potential investors. This is your chance to capitalize.

Today, we have a much clearer view of how the cannabis industry will ultimately shake out. We’ve learned critical lessons that should successfully guide new investment dollars. Investing after a bear market can be scary, but it can often be more lucrative, and counter-intuitively, less risky.

Want to buy pot stocks in 2020? Here’s how to invest.

Partners will be critical

If you want to make money in pot, it pays to heed the lessons of the past. Clues of what’s ahead can be gleaned from markets that went through a similar evolution, such as the tobacco market.

According to the Wall Street Journal, the story of the tobacco market has been one of consolidation, aggregating power to the most connected and well-financed operators.

“A flurry of consolidation has winnowed the U.S. tobacco market from seven big players to two: Altria and Newport-maker Reynolds American Inc., which together sell eight out of every 10 cigarettes in the country,” the paper reported. “As companies combined, they squeezed out costs and increased pricing power, along with profits.”

The same story played out in Canada, where in 2019, just three companies controlled 99% of the market. Here’s the lesson: invest in pot stocks with powerful partners.

The right partner can make all the difference as the pot market consolidates over the next decade and beyond.

The first advantage is capital. Few pot companies today are profitable, so the ability to tap the financing capabilities of a multi-billion dollar partner cannot be over-appreciated.

The second advantage is influence. With a longer history of prohibition and strict regulatory oversight, marijuana will remain highly scrutinized and controlled. Having a partner that has navigated these types of markets successfully for decades is a huge plus.

The last advantage is expertise. The right partner likely has a proven history of creating brands that consumers know and love. As the pot industry experiences rampant commoditization, differentiation will be more important than ever.

With this in mind, pot stocks like Aurora Cannabis Inc could be at a disadvantage. While the company has forged a variety of deals that put the company in a promising position, it still lacks the weight of a blue-chip partner. This leaves it largely up to its own devices. To succeed long term, Aurora will need to execute without much outside help.

Cronos Group (TSX:CRON)(NASDAQ:CRON), on the other hand, has already secured one of the most powerful partners imaginable: tobacco giant Altria Group Inc (NYSE:MO). Altria has already invested billions of dollars, making Cronos its exclusive partner in the cannabis space.

I simply cannot think of a more valuable partner for the years ahead. Altria’s $100 billion market cap and investment-grade rating give it an unparalleled ability to out-invest the rest of the cannabis industry. Its multi-decade history of success also cannot be matched by any existing cannabis partner. Finally, its record of creating world-renowned brands such as Marlboro should give Cronos a huge advantage when it comes to differentiation.

Which company is more likely to succeed long term: Aurora or Cronos? Judging by history, my money is on Cronos.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »

A cannabis plant grows.
Cannabis Stocks

Can Aurora Cannabis Stock Recover in 2024?

Aurora Cannabis stock is down 99% from all-time highs but remains a high-risk bet, despite its cheap valuation.

Read more »